215 related articles for article (PubMed ID: 34519230)
1. Tailoring thixotropic mixed-lipid nanoconstructs of voriconazole for the management of Vulvovaginal candidiasis: Formulation, statistical optimization,
Abd-Elsalam WH; Nagy YI; Abouelatta SM
Drug Deliv; 2021 Dec; 28(1):1877-1889. PubMed ID: 34519230
[TBL] [Abstract][Full Text] [Related]
2. Surface-modified mucoadhesive microgels as a controlled release system for miconazole nitrate to improve localized treatment of vulvovaginal candidiasis.
Kenechukwu FC; Attama AA; Ibezim EC; Nnamani PO; Umeyor CE; Uronnachi EM; Gugu TH; Momoh MA; Ofokansi KC; Akpa PA
Eur J Pharm Sci; 2018 Jan; 111():358-375. PubMed ID: 28986195
[TBL] [Abstract][Full Text] [Related]
3. Nanolipid Gel of an Antimycotic Drug for Treating Vulvovaginal Candidiasis-Development and Evaluation.
Takalkar D; Desai N
AAPS PharmSciTech; 2018 Apr; 19(3):1297-1307. PubMed ID: 29340981
[TBL] [Abstract][Full Text] [Related]
4. Statistical optimization of hyaluronic acid enriched ultradeformable elastosomes for ocular delivery of voriconazole via Box-Behnken design:
Fahmy AM; Hassan M; El-Setouhy DA; Tayel SA; Al-Mahallawi AM
Drug Deliv; 2021 Dec; 28(1):77-86. PubMed ID: 33342315
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections.
Dudhipala N; Ay AA
Chem Phys Lipids; 2020 Oct; 232():104953. PubMed ID: 32814084
[TBL] [Abstract][Full Text] [Related]
7. Development, optimization, and evaluation of a nanostructured lipid carrier of sesame oil loaded with miconazole for the treatment of oral candidiasis.
Hosny KM; Sindi AM; Ali S; Alharbi WS; Hajjaj MS; Bukhary HA; Badr MY; Mushtaq RY; Murshid SSA; Almehmady AM; Bakhaidar RB; Alfayez E; Kurakula M
Drug Deliv; 2022 Dec; 29(1):254-262. PubMed ID: 35014929
[No Abstract] [Full Text] [Related]
8. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
9. Bioadhesive vaginal drug delivery of nystatin using a derivatized polymer: Development and characterization.
Bassi P; Kaur G
Eur J Pharm Biopharm; 2015 Oct; 96():173-84. PubMed ID: 26235393
[TBL] [Abstract][Full Text] [Related]
10. Formulation, optimization, and nephrotoxicity evaluation of an antifungal in situ nasal gel loaded with voriconazole‒clove oil transferosomal nanoparticles.
Kammoun AK; Khedr A; Hegazy MA; Almalki AJ; Hosny KM; Abualsunun WA; Murshid SSA; Bakhaidar RB
Drug Deliv; 2021 Dec; 28(1):2229-2240. PubMed ID: 34668818
[TBL] [Abstract][Full Text] [Related]
11. Curcumin-Loaded Liquid Crystalline Systems for Controlled Drug Release and Improved Treatment of Vulvovaginal Candidiasis.
Rodero CF; Fioramonti Calixto GM; Cristina Dos Santos K; Sato MR; Aparecido Dos Santos Ramos M; Miró MS; Rodríguez E; Vigezzi C; Bauab TM; Sotomayor CE; Chorilli M
Mol Pharm; 2018 Oct; 15(10):4491-4504. PubMed ID: 30184431
[TBL] [Abstract][Full Text] [Related]
12. Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity.
Aljaeid BM; Hosny KM
Int J Nanomedicine; 2016; 11():441-7. PubMed ID: 26869787
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against
Tian B; Yan Q; Wang J; Ding C; Sai S
Int J Nanomedicine; 2017; 12():7131-7141. PubMed ID: 29026306
[No Abstract] [Full Text] [Related]
14. The role of formulation and follicular pathway in voriconazole cutaneous delivery from liposomes and nanostructured lipid carriers.
Santos GA; Angelo T; Andrade LM; Silva SMM; Magalhães PO; Cunha-Filho M; Gelfuso GM; Taveira SF; Gratieri T
Colloids Surf B Biointerfaces; 2018 Oct; 170():341-346. PubMed ID: 29940500
[TBL] [Abstract][Full Text] [Related]
15. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D
Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301
[TBL] [Abstract][Full Text] [Related]
16. Influence of formulation variables on miconazole nitrate-loaded lipid based nanocarrier for topical delivery.
Al-Maghrabi PM; Khafagy ES; Ghorab MM; Gad S
Colloids Surf B Biointerfaces; 2020 Sep; 193():111046. PubMed ID: 32416518
[TBL] [Abstract][Full Text] [Related]
17. Voriconazole incorporated nanofiber formulations for topical application: preparation, characterization and antifungal activity studies against
Esentürk İ; Balkan T; Özhan G; Döşler S; Güngör S; Erdal MS; Sarac AS
Pharm Dev Technol; 2020 Apr; 25(4):440-453. PubMed ID: 31851857
[TBL] [Abstract][Full Text] [Related]
18. New therapeutic system based on hydrogels for vaginal candidiasis management: formulation-characterization and
Arpa MD; Yoltaş A; Onay Tarlan E; Şenyüz CŞ; Sipahi H; Aydın A; Üstündağ Okur N
Pharm Dev Technol; 2020 Dec; 25(10):1238-1248. PubMed ID: 32787718
[TBL] [Abstract][Full Text] [Related]
19. Investigation of thiosemicarbazide free or within chitosan nanoparticles in a murine model of vulvovaginal candidiasis.
Araújo DE; de Oliveira AA; Cabral MDS; Costa AF; Silva BC; do Carmo Silva L; de Menezes LB; de Almeida Soares CM; Amaral AC; Pereira M
Braz J Microbiol; 2020 Dec; 51(4):1465-1473. PubMed ID: 32638273
[TBL] [Abstract][Full Text] [Related]
20. Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis.
de Oliveira Neto AS; Souza ILA; Amorim MES; de Freitas Souza T; Rocha VN; do Couto RO; Fabri RL; de Freitas Araújo MG
Med Mycol; 2021 May; 59(5):476-485. PubMed ID: 32823281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
